1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LILLY(ELI) & CO
Lilly(Eli) & Co XNYS: LLY

Lilly(Eli) & Co Live Stock Price Today, Share Analysis and Chart

Expensive Performer
about

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumia...

Read More
760.08 -2.87 (-0.38%)
4.3M
XNYS Volume

XNYS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Dividend
Lilly(Eli) & Co has an upcoming dividend of $1.50 per share due on 15 Aug 2025 See details
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Expensive Valuation
26.0 / 100
Momentum Score
Technically Neutral
41.3 / 100
Expensive Performer These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM
Analyst Price Target
963
1Yr Price target upside is 27%
26 analysts

5

S

13

W

5

O

0

T

SWOT Analysis

Eli Lilly Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..